Literature DB >> 18654886

A rare thalassemic syndrome caused by interaction of Hb Adana [alpha59(E8)Gly-->Asp] with an alpha+-thalassemia deletion: clinical aspects in two cases.

Varvara Douna1, Ioannis Papassotiriou, Anastasia Garoufi, Eleni Georgouli, Vassilis Ladis, Alexandra Stamoulakatou, Anna Metaxotou-Mavrommati, Emmanuel Kanavakis, Joanne Traeger-Synodinos.   

Abstract

Hb Adana is a highly unstable and rare alpha-globin hemoglobin (Hb) variant, to date described in only three families, in interaction with other alpha-thalassemia (alpha-thal) deletions. We describe the clinical and hematological findings in two cases from independent families of Albanian origin, who have an interaction of the codon 59 (Gly-->Asp) alpha2-globin gene variant in trans to a 3.7 kb alpha(+)-thal deletion (alpha(codon 59)alpha/-alpha). We report their presenting symptoms and laboratory findings as well as complications and differences in their clinical management. Both cases can be characterized as thalassemia intermedia and illustrate the problems associated with selecting the most appropriate options for patient management, especially in cases with rare underlying genotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654886     DOI: 10.1080/03630260802173890

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Α case of late diagnosis of compound heterozygosity for Hb Adana (HBA2:c.179G>A) in trans to an α+- thalassemia deletion: guilty or innocent.

Authors:  A Tampaki; S Theodoridou; Ch Apostolou; E E Delaki; E Vlachaki
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  Severe α-thalassemia intermedia due to a compound heterozygosity for the highly unstable Hb Adana (HBA2: c.179G>A) and a novel codon 24 (HBA2: c.75T>A) mutation.

Authors:  Dewi Megawati; Ita M Nainggolan; Maria Swastika; Susi Susanah; Johanes C Mose; Alida R Harahap; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2013-12-18       Impact factor: 0.849

3.  DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia.

Authors:  Jin Ai Mary Anne Tan; Siew Leng Kho; Chin Fang Ngim; Kek Heng Chua; Ai Sim Goh; Seoh Leng Yeoh; Elizabeth George
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

4.  Interaction of Hb adana (HBA2: c.179G>A) with deletional and nondeletional α(+)-thalassemia mutations: diverse hematological and clinical features.

Authors:  Ita M Nainggolan; Alida Harahap; Debby D Ambarwati; Rosalina V Liliani; Dewi Megawati; Maria Swastika; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2013-04-25       Impact factor: 0.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.